Work life balance bad.
Pay is low relative to the work life balance and competitors.
No merit bonus even for fairly high managers, just 5-7% profit sharing.
Dead wood: Either 20 year old Abbott management, or new management brought in from dying big pharma.
Common statements: That is how we always have done it from middle management. I thought that last statement was something that nobody would ever say at any company. I almost fell over, the first time I heard it.
IT new and broken outsourced.
it is likely Abbvie will be bought out if it can't fill the Humara hole.
Very top management spins that the company is going to be a light nimble biotech, but the reality is very different in key areas.
401K middle of the road for Pharma.
No stock options for even middle management.
Current department has high turnover of new people joining jumping and being replaced by new people.